https://www.selleckchem.com/pr....oducts/5-cholesten-3
7 for incident HF and 2.1 for CVD events, both p less then 0.01). In conclusion, the combination of both biomarkers to traditional risk factors in participants who were normoglycemic or with pre-DM or DM improved risk prediction for both incident HF and total CVD events in an ethnically diverse population. Limited data exist regarding the timing of percutaneous coronary intervention (PCI) in patients with coronary artery disease who underwent transcatheter aortic valve implantation (TAVI). We aimed to investigate clin
Like
Comment
Share
